Implications of the incidentalome for clinical pharmacogenomics.
Implications of the incidentalome for clinical pharmacogenomics.
复制标题
DOI：
10.2217/pgs.13.119
复制
发表时间：
2013-08
期刊：
影响因子：
2.1
通讯作者：
Erdmann P
中科院分区：
文献类型：
--
作者：
Brothers KB;Langanke M;Erdmann P
Incidental findings have long posed challenges for healthcare providers, but the scope and scale of these challenges have increased with the introduction of new technologies. This article assesses the impact of incidental findings on the introduction of prospective pharmacogenomic testing into clinical use. Focusing on the challenges of the incidentalome, the large set of incidental findings potentially generated through genotyping, the paper argues that provisional approaches to managing incidental findings may be implemented if necessary to allow benefits of pharmacogenomic testing to be realized in the clinical setting. In the longer term, approaches to returning incidental findings may need to focus on limiting the number of incidental findings to a number that can be addressed by patients and providers.
登录
查看更多内容
影响因子：
6.7
作者：
通讯作者：
--
DOI：
10.1038/gim.2013.73
发表时间：
2013-07
期刊：
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子：
--
作者：
通讯作者：
--
影响因子：
3.6
作者：
Owens, H;Siparsky, G;Hampers, LC
通讯作者：
Hampers, LC
影响因子：
13.4
作者：
Murphy, Juli;Scott, Joan;Hudson, Kathy
通讯作者：
Hudson, Kathy
影响因子：
0.6
作者：
Rudnik-Schoeneborn, Sabine;Langanke, Martin;Robienski, Juergen
通讯作者：
Robienski, Juergen